24 Oktober 2016 08:00 AM Eastern Daylight Time

BUSINESS WIRE

St. Jude Medical kündigt Präsentation von Daten aus brandaktuellen klinische Studien an und stellt sein neuestes Portfolio zu Herz-Kreislauf-Behandlungen auf TCT-Konferenz 2016 in den Mittelpunkt

In voller Größe anschauen

Opens in new window

Download-Formate

Volle Größe JPEG, 3000x553, 171.5 KB
Klein JPEG, 480x88, 17.2 KB
Vorschau im JPEG-Format JPEG, 144x27, 4.8 KB
Kleinbild im JPEG-Format JPEG, 120x22, 3.7 KB

Smart Multimedia-Galerie

St. Jude Medical will have new data featured during late-breaking clinical trial presentations at the upcoming 2016 Transcatheter Cardiovascular Therapeutics symposium. Throughout the congress, the company will also feature its latest cardiovascular innovations that demonstrate its commitment to transforming the treatment of cardiovascular disease. (Photo: Business Wire)

St. Jude Medical will have new data featured during late-breaking clinical trial presentations at the upcoming 2016 Transcatheter Cardiovascular Therapeutics symposium. Throughout the congress, the company will also feature its latest cardiovascular innovations that demonstrate its commitment to transforming the treatment of cardiovascular disease. (Photo: Business Wire)

View and Share Foto

Download-Formate Klein

http://www.businesswire.de/multimedia/de/20161024005328/de/3908835/

Share

E-Mail

Alle Nachrichten | Nachrichten mit Fotos & Multimedia > Pressemitteilung: St. Jude Medical kündigt Präsentation von Daten...

Weitere Business Wire-Websites